DuCLOX-2/5 Inhibition Attenuates Inflammatory Response and Induces Mitochondrial Apoptosis for Mammary Gland Chemoprevention

The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 9; p. 314
Main Authors Gautam, Swetlana, Rawat, Atul K., Sammi, Shreesh R., Roy, Subhadeep, Singh, Manjari, Devi, Uma, Yadav, Rajnish K., Singh, Lakhveer, Rawat, Jitendra K., Ansari, Mohd N., Saeedan, Abdulaziz S., Kumar, Dinesh, Pandey, Rakesh, Kaithwas, Gaurav
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.
AbstractList The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1 H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.
The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.
The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.
The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.
Author Ansari, Mohd N.
Rawat, Jitendra K.
Devi, Uma
Saeedan, Abdulaziz S.
Pandey, Rakesh
Rawat, Atul K.
Singh, Lakhveer
Kaithwas, Gaurav
Gautam, Swetlana
Singh, Manjari
Yadav, Rajnish K.
Kumar, Dinesh
Sammi, Shreesh R.
Roy, Subhadeep
AuthorAffiliation 2 Center for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Sciences Campus , Lucknow , India
4 Department of Pharmaceutical Sciences, Faculty of Health and Medical Sciences, Sam Higginbottom Institute of Agricultural Sciences and Technology , Allahabad , India
1 Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University) , Lucknow , India
5 Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj , Saudi Arabia
3 Department of Microbial Technology and Nematology, CSIR-Central Institute of Medicinal and Aromatic Plants , Lucknow , India
AuthorAffiliation_xml – name: 3 Department of Microbial Technology and Nematology, CSIR-Central Institute of Medicinal and Aromatic Plants , Lucknow , India
– name: 2 Center for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Sciences Campus , Lucknow , India
– name: 4 Department of Pharmaceutical Sciences, Faculty of Health and Medical Sciences, Sam Higginbottom Institute of Agricultural Sciences and Technology , Allahabad , India
– name: 1 Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University) , Lucknow , India
– name: 5 Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj , Saudi Arabia
Author_xml – sequence: 1
  givenname: Swetlana
  surname: Gautam
  fullname: Gautam, Swetlana
– sequence: 2
  givenname: Atul K.
  surname: Rawat
  fullname: Rawat, Atul K.
– sequence: 3
  givenname: Shreesh R.
  surname: Sammi
  fullname: Sammi, Shreesh R.
– sequence: 4
  givenname: Subhadeep
  surname: Roy
  fullname: Roy, Subhadeep
– sequence: 5
  givenname: Manjari
  surname: Singh
  fullname: Singh, Manjari
– sequence: 6
  givenname: Uma
  surname: Devi
  fullname: Devi, Uma
– sequence: 7
  givenname: Rajnish K.
  surname: Yadav
  fullname: Yadav, Rajnish K.
– sequence: 8
  givenname: Lakhveer
  surname: Singh
  fullname: Singh, Lakhveer
– sequence: 9
  givenname: Jitendra K.
  surname: Rawat
  fullname: Rawat, Jitendra K.
– sequence: 10
  givenname: Mohd N.
  surname: Ansari
  fullname: Ansari, Mohd N.
– sequence: 11
  givenname: Abdulaziz S.
  surname: Saeedan
  fullname: Saeedan, Abdulaziz S.
– sequence: 12
  givenname: Dinesh
  surname: Kumar
  fullname: Kumar, Dinesh
– sequence: 13
  givenname: Rakesh
  surname: Pandey
  fullname: Pandey, Rakesh
– sequence: 14
  givenname: Gaurav
  surname: Kaithwas
  fullname: Kaithwas, Gaurav
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29681851$$D View this record in MEDLINE/PubMed
BookMark eNp1Ul1rFDEUDVKxtfbdJ5lHX2abj0kmeRGWVevCloIo-BYy-eikzE7GJFMQ_PFmdltpBQMh4d5zzk3uPa_ByRhGC8BbBFeEcHHppl7FFYaIryAkqHkBzhBjpBYc4ZMn91NwkdIdLIsIQVjzCpxiwTjiFJ2B3x_nze7mR40vabUde9_57MNYrXO246yyTSXqBrXfqxzir-qrTVMYk63UaErGzLogrn0Oug-jiV4N1XoKUw7Jp8qFWF0v1EK8GhbGprf7MEV7b8elzBvw0qkh2YuH8xx8__zp2-ZLvbu52m7Wu1o3DOe6g4RhQhFVFmpMu7KpQ8ogh6gzQrcWE0Mc1NpY1LaaG4yRg1xA3VIONTkH26OuCepOTtEvT5JBeXkIhHgrVcxeD1Y2ou06iKnB3DW4s5wp7KBqmMWtaPii9eGoNc3d3hpdfhLV8Ez0eWb0vbwN95Jy0TLKisD7B4EYfs42Zbn3SduhNMiGOUkMy3QIwmiBvnta62-Rx_EVADsCdAwpReuk9lktrS2l_SARlItV5MEqcrGKPFilEOE_xEft_1L-AOOdxAg
CitedBy_id crossref_primary_10_1002_jbt_70016
crossref_primary_10_1016_j_jgeb_2025_100480
crossref_primary_10_1002_cbf_3513
crossref_primary_10_1007_s00210_019_01658_7
crossref_primary_10_1002_jcp_27168
crossref_primary_10_1186_s12860_021_00371_9
crossref_primary_10_3389_fcell_2021_736910
crossref_primary_10_1016_j_bioorg_2022_106147
crossref_primary_10_1038_s41598_020_67420_9
crossref_primary_10_1016_j_bbadis_2020_165713
crossref_primary_10_3389_fphar_2021_788977
crossref_primary_10_1186_s12885_019_6152_9
crossref_primary_10_1177_0960327120931165
Cites_doi 10.1016/j.tcb.2017.05.001
10.1016/j.physbeh.2017.10.024
10.1093/carcin/bgi012
10.1101/cshperspect.a008656
10.1093/nar/gkl923
10.1007/s10787-009-8049-8
10.1007/s12282-016-0723-2
10.1007/s10787-016-0280-5
10.1039/C7RA09689E
10.2174/2213235X04666160809123143
10.1093/glycob/cwm100
10.4172/jpb.1000111
10.1242/jcs.073643
10.1016/0016-5085(94)90246-1
10.1038/nrc3365
10.1073/pnas.76.9.4350
10.1093/nar/gkp356
10.1056/NEJM200006293422606
10.1006/meth.2001.1261
10.1046/j.1365-2036.2000.014s1064.x
10.1006/niox.2001.0420
10.1007/s10555-011-9310-3
10.1016/j.biocel.2018.01.011
10.1038/bjc.2013.280
10.1186/s12906-016-1243-5
10.1146/annurev-nutr-071811-150726
10.1016/S0090-6980(02)00030-8
10.1016/j.yexcr.2006.03.027
10.1007/s004320000225
10.1093/jnci/djp440
10.5306/wjco.v5.i4.677
10.1016/j.cmet.2007.10.002
10.1016/j.canlet.2013.09.011
10.1126/science.1160809
10.1016/S0092-8674(02)00703-1
10.1024/0300-9831/a000064
10.1038/227680a0
10.1093/glycob/cwh025
10.1186/1471-2407-7-138
10.1186/1471-2407-9-267
10.1006/bbrc.1999.1840
10.1002/mrc.4094
10.1016/j.cell.2010.03.014
10.1186/s40170-015-0128-2
10.1038/nrc2618
10.1038/ncomms10558
10.3390/ijms141021167
10.1093/nar/gkv380
10.1002/ejlt.201100263
10.18632/oncotarget.19551
10.1006/excr.1999.4501
10.1016/j.prostaglandins.2011.08.004
10.1038/nrcardio.2010.121
10.1023/A:1015579209850
10.4103/0975-7406.199339
10.1111/j.1365-2273.1991.tb00975.x
10.4331/wjbc.v3.i8.167
10.1074/jbc.275.12.8461
10.1186/s12944-016-0225-4
ContentType Journal Article
Copyright Copyright © 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas. 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas
Copyright_xml – notice: Copyright © 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas. 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2018.00314
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c
PMC5897656
29681851
10_3389_fphar_2018_00314
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-b03623515ae0c25bc255f1ad1f15fd9c7e23d3f0ccde177c8d221f0890c7580c3
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:31:08 EDT 2025
Thu Aug 21 18:17:05 EDT 2025
Fri Jul 11 01:05:53 EDT 2025
Thu Apr 03 07:04:22 EDT 2025
Thu Apr 24 23:04:21 EDT 2025
Tue Jul 01 02:25:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords lipoxygenase
NMR
DuCLOX-2/5 inhibition
angiogenesis
apoptosis
cyclooxygenase
Zaltoprofen
Zileuton
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-b03623515ae0c25bc255f1ad1f15fd9c7e23d3f0ccde177c8d221f0890c7580c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Anna Rita Migliaccio, Icahn School of Medicine at Mount Sinai, United States
This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Pharmacology
Reviewed by: Harikumar K.B., Rajiv Gandhi Centre for Biotechnology, India; Fabrizio Martelli, Istituto Superiore di Sanità, Italy
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2018.00314
PMID 29681851
PQID 2029631216
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5897656
proquest_miscellaneous_2029631216
pubmed_primary_29681851
crossref_citationtrail_10_3389_fphar_2018_00314
crossref_primary_10_3389_fphar_2018_00314
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-06
PublicationDateYYYYMMDD 2018-04-06
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-06
  day: 06
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2018
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Laemmli (B34) 1970; 227
Rawat (B47); 5
Nie (B40) 2001; 20
Murray (B38) 2009; 9
Gautam (B16) 2018; 8
Kawai (B32) 2002; 68
Jobard (B27) 2014; 343
McIlwain (B37) 2013; 5
Wallace (B59) 2012; 12
Manral (B35) 2016; 16
Giulietti (B18) 2001; 25
Ghosh (B17) 2002; 109
Schneider (B53) 2011; 30
Cheung (B8) 2006; 312
EI-Hakim (B21) 1991; 16
Rani (B44) 2018; 183
Saldova (B52) 2007; 17
Zhuang (B66) 1999; 250
Ahn (B2) 2015; 3
Wishart (B60) 2007; 35
Greene (B19) 2011; 96
Harris (B24) 2014; 5
DeBerardinis (B9) 2008; 7
Xia (B62) 2015; 43
Belur (B4) 1990
Eberhart (B12) 1994; 107
Ewer (B13) 2010; 7
Joyce (B28) 2009; 9
Martinez (B36) 2004; 14
Rawat (B46); 8
Dempke (B10) 2001; 127
Kaithwas (B30) 2011; 49
Bratton (B6) 2010; 123
Zhang (B64) 2012; 3
Schutz (B55) 2011; 81
Qian (B42) 2010; 141
Ye (B63) 2005; 26
Kaithwas (B31) 2012; 114
Russo (B51) 1990
Xia (B61) 2009; 37
Ahmad (B1) 2009; 2
Flote (B14) 2016; 15
Rani (B43) 2016; 24
Roy (B49) 2017; 8
Dubois (B11) 2000; 14
Hammamieh (B22) 2007; 7
Jänne (B26) 2000; 342
Roy (B50) 2018; 96
Ristimäki (B48) 2002; 62
Guleria (B20) 2014; 52
Bustamante (B7) 2002; 6
Vander Heiden (B58) 2009; 324
Kumar (B33) 2016
Gautam (B15) 2016; 24
Schroeder (B54) 2007; 6
Kaithwas (B29) 2007; 3
Nie (B41) 2000; 267
Raphael (B45) 2013; 14
Zhang (B65) 2012; 32
Towbin (B57) 1979; 76
Newman (B39) 2017; 27
Steward (B56) 2013; 109
Benedict (B5) 2000; 275
Harris (B23) 2009; 17
Albini (B3) 2010; 102
Hartiala (B25) 2016; 7
References_xml – volume: 27
  start-page: 645
  year: 2017
  ident: B39
  article-title: Serine and functional metabolites in Cancer
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2017.05.001
– volume: 183
  start-page: 49
  year: 2018
  ident: B44
  article-title: Effects of minocycline and doxycycline against terbutaline induced early postnatal autistic changes in albino rats
  publication-title: Physiol. Behav.
  doi: 10.1016/j.physbeh.2017.10.024
– volume: 26
  start-page: 827
  year: 2005
  ident: B63
  article-title: Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi012
– volume: 62
  start-page: 632
  year: 2002
  ident: B48
  article-title: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
  publication-title: Cancer Res
– volume: 5
  start-page: a008656
  year: 2013
  ident: B37
  article-title: Caspase functions in cell death and disease
  publication-title: Cold Spring Harbor Perspect. Biol
  doi: 10.1101/cshperspect.a008656
– volume: 35
  start-page: D521
  year: 2007
  ident: B60
  article-title: HMDB: the human metabolome database
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkl923
– volume: 17
  start-page: 55
  year: 2009
  ident: B23
  article-title: Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
  publication-title: Inflammopharmacology
  doi: 10.1007/s10787-009-8049-8
– volume: 24
  start-page: 180
  year: 2016
  ident: B15
  article-title: DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention
  publication-title: Breast Cancer
  doi: 10.1007/s12282-016-0723-2
– volume: 24
  start-page: 277
  year: 2016
  ident: B43
  article-title: α-Chymotrypsin regulates free fatty acids and UCHL-1 to ameliorate N-methyl nitrosourea induced mammary gland carcinoma in albino wistar rats
  publication-title: Inflammopharmacology
  doi: 10.1007/s10787-016-0280-5
– volume: 8
  start-page: 3512
  year: 2018
  ident: B16
  article-title: Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer
  publication-title: RSC Adv
  doi: 10.1039/C7RA09689E
– volume: 5
  start-page: 55
  ident: B47
  article-title: Serum metabolic disturbances hailing in initial hours of acute myocardial infarction elucidated by NMR based metabolomics
  publication-title: Curr. Metabolomics
  doi: 10.2174/2213235X04666160809123143
– volume: 17
  start-page: 1344
  year: 2007
  ident: B52
  article-title: Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwm100
– volume: 2
  start-page: 495
  year: 2009
  ident: B1
  article-title: An effective method for the analysis of human plasma proteome using two-dimensional gel electrophoresis
  publication-title: J. Proteomics Bioinform.
  doi: 10.4172/jpb.1000111
– volume: 123
  start-page: 3209
  year: 2010
  ident: B6
  article-title: Regulation of the Apaf-1– caspase-9 apoptosome
  publication-title: J. Cell Sci
  doi: 10.1242/jcs.073643
– volume: 107
  start-page: 1183
  year: 1994
  ident: B12
  article-title: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
  publication-title: Gastroenterol
  doi: 10.1016/0016-5085(94)90246-1
– volume: 12
  start-page: 685
  year: 2012
  ident: B59
  article-title: Mitochondria and cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3365
– volume: 76
  start-page: 4350
  year: 1979
  ident: B57
  article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.76.9.4350
– volume: 37
  start-page: W652
  year: 2009
  ident: B61
  article-title: MetaboAnalyst: a web server for metabolomic data analysis and interpretation
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkp356
– volume: 342
  start-page: 1960
  year: 2000
  ident: B26
  article-title: Chemoprevention of colorectal cancer
  publication-title: N. Engl. J. Med
  doi: 10.1056/NEJM200006293422606
– volume: 25
  start-page: 386
  year: 2001
  ident: B18
  article-title: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression
  publication-title: Methods
  doi: 10.1006/meth.2001.1261
– volume: 14
  start-page: 64
  year: 2000
  ident: B11
  article-title: Review article: cyclooxygenase–a target for colon cancer prevention
  publication-title: Aliment. Pharmacol. Ther
  doi: 10.1046/j.1365-2036.2000.014s1064.x
– volume: 6
  start-page: 183
  year: 2007
  ident: B54
  article-title: Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines
  publication-title: J. Exp. Ther. Oncol
– volume: 6
  start-page: 333
  year: 2002
  ident: B7
  article-title: Sequential NO production by mitochondria and endoplasmic reticulum during induced apoptosis
  publication-title: Nitric Oxide
  doi: 10.1006/niox.2001.0420
– volume: 30
  start-page: 277
  year: 2011
  ident: B53
  article-title: Cyclooxygenases and lipoxygenases in cancer
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-011-9310-3
– volume: 96
  start-page: 51
  year: 2018
  ident: B50
  article-title: GLA supplementation regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DMBA induced mammary gland carcinoma
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2018.01.011
– volume: 109
  start-page: 1
  year: 2013
  ident: B56
  article-title: Cancer chemoprevention: a rapidly evolving field
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2013.280
– volume: 16
  start-page: 260
  year: 2016
  ident: B35
  article-title: Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats
  publication-title: BMC Complement. Altern. Med
  doi: 10.1186/s12906-016-1243-5
– volume: 32
  start-page: 203
  year: 2012
  ident: B65
  article-title: Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids
  publication-title: Annu. Rev. Nutr.
  doi: 10.1146/annurev-nutr-071811-150726
– volume: 68
  start-page: 187
  year: 2002
  ident: B32
  article-title: Cyclooxygenases and colon cancer
  publication-title: Prostaglandins Other Lipid Mediat.
  doi: 10.1016/S0090-6980(02)00030-8
– volume: 312
  start-page: 2347
  year: 2006
  ident: B8
  article-title: Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs
  publication-title: Exp. Cell Res
  doi: 10.1016/j.yexcr.2006.03.027
– volume: 127
  start-page: 411
  year: 2001
  ident: B10
  article-title: Cyclooxygenase-2: a novel target for cancer chemotherapy?
  publication-title: J. Cancer Res. Clin. Oncol
  doi: 10.1007/s004320000225
– volume: 102
  start-page: 14
  year: 2010
  ident: B3
  article-title: Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/djp440
– volume: 5
  start-page: 677
  year: 2014
  ident: B24
  article-title: Cyclooxygenase-2 and the inflammogenesis of breast cancer
  publication-title: World J. Clin. Oncol
  doi: 10.5306/wjco.v5.i4.677
– volume: 7
  start-page: 11
  year: 2008
  ident: B9
  article-title: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2007.10.002
– volume: 343
  start-page: 33
  year: 2014
  ident: B27
  article-title: A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2013.09.011
– volume: 324
  start-page: 1029
  year: 2009
  ident: B58
  article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation
  publication-title: Science
  doi: 10.1126/science.1160809
– volume: 109
  start-page: S81
  year: 2002
  ident: B17
  article-title: Missing pieces in the NF-κB puzzle
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00703-1
– start-page: 217
  volume-title: Pathology Reviews
  year: 1990
  ident: B51
  article-title: Comparative study of human and rat mammary tumorigenesis
– volume: 81
  start-page: 101
  year: 2011
  ident: B55
  article-title: Protein turnover, ureagenesis and gluconeogenesis
  publication-title: Int. J. Vitam. Nutr. Res.
  doi: 10.1024/0300-9831/a000064
– volume: 227
  start-page: 680
  year: 1970
  ident: B34
  article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4
  publication-title: Nature
  doi: 10.1038/227680a0
– volume: 14
  start-page: 127
  year: 2004
  ident: B36
  article-title: Galectin-1, a cell adhesion modulator, induces apoptosis of rat leyding cells in vitro
  publication-title: Glycobiol
  doi: 10.1093/glycob/cwh025
– volume: 7
  start-page: 138
  year: 2007
  ident: B22
  article-title: Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-138
– volume: 9
  start-page: 267
  year: 2009
  ident: B38
  article-title: Histological analysis of low dose NMU effects in the rat mammary gland
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-267
– volume: 267
  start-page: 245
  year: 2000
  ident: B41
  article-title: Thromboxane A 2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
  publication-title: Biochem. Biophys. Res. Commun
  doi: 10.1006/bbrc.1999.1840
– volume: 52
  start-page: 475
  year: 2014
  ident: B20
  article-title: Metabolite characterisation in peritoneal dialysis effluent using highâ resolution 1H and 1H-13C NMR spectroscopy
  publication-title: Magn. Reson. Chem.
  doi: 10.1002/mrc.4094
– start-page: 1
  volume-title: Nuclear Magnetic Resonance Spectroscopy
  year: 2016
  ident: B33
  article-title: NMR based metabolomics: an emerging tool for therapeutic evaluation of traditional herbal medicines
– volume: 141
  start-page: 39
  year: 2010
  ident: B42
  article-title: Macrophage diversity enhances tumor progression and metastasis
  publication-title: Cell
  doi: 10.1016/j.cell.2010.03.014
– volume: 3
  start-page: 1
  year: 2015
  ident: B2
  article-title: Mitochondria as biosynthetic factories for cancer proliferation
  publication-title: Cancer Metab.
  doi: 10.1186/s40170-015-0128-2
– volume: 9
  start-page: 239
  year: 2009
  ident: B28
  article-title: Microenvironmental regulation of metastasis
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2618
– volume: 7
  start-page: 10558
  year: 2016
  ident: B25
  article-title: Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease
  publication-title: Nat Commun.
  doi: 10.1038/ncomms10558
– volume-title: Laboratory Technology–A Procedure Manual for Routine Diagnostic Tests
  year: 1990
  ident: B4
– volume: 14
  start-page: 21167
  year: 2013
  ident: B45
  article-title: Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms141021167
– volume: 43
  start-page: W251
  year: 2015
  ident: B62
  article-title: MetaboAnalyst 3.0– making metabolomics more meaningful
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv380
– volume: 114
  start-page: 1237
  year: 2012
  ident: B31
  article-title: In vitro antioxidant and in vivo antidiabetic, antihyperlipidemic activity of linseed oil against streptozotocin-induced toxicity in albino rats
  publication-title: Eur. J. Lipid Sci. Technol
  doi: 10.1002/ejlt.201100263
– volume: 8
  start-page: 70049
  year: 2017
  ident: B49
  article-title: Alpha-linolenic acid stabilizes HIF-1 α and downregulates FASN to promote mitochondrial apoptosis for mammary gland chemoprevention
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.19551
– volume: 250
  start-page: 203
  year: 1999
  ident: B66
  article-title: Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells
  publication-title: Exp. Cell Res.
  doi: 10.1006/excr.1999.4501
– volume: 96
  start-page: 27
  year: 2011
  ident: B19
  article-title: Regulation of inflammation in cancer by eicosanoids
  publication-title: Prostaglandins Other Lipid Mediat
  doi: 10.1016/j.prostaglandins.2011.08.004
– volume: 7
  start-page: 564
  year: 2010
  ident: B13
  article-title: Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
  publication-title: Nat. Rev. Cardiol
  doi: 10.1038/nrcardio.2010.121
– volume: 3
  start-page: 428
  year: 2007
  ident: B29
  article-title: Reversal of sodium nitrite induced impairment of spontaneous alteration by Aloe vera gel: involvement of cholinergic system
  publication-title: Pharmacologyonline.
– volume: 20
  start-page: 195
  year: 2001
  ident: B40
  article-title: Role of eicosanoids in prostate cancer progression
  publication-title: Cancer Metastasis Rev
  doi: 10.1023/A:1015579209850
– volume: 8
  start-page: 327
  ident: B46
  article-title: 1H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats
  publication-title: J. Pharm. Bioallied Sci.
  doi: 10.4103/0975-7406.199339
– volume: 16
  start-page: 563
  year: 1991
  ident: B21
  article-title: Arachidonic acid cascade and oral squamous cell carcinoma
  publication-title: Clin. Otolaryngol
  doi: 10.1111/j.1365-2273.1991.tb00975.x
– volume: 49
  start-page: 260
  year: 2011
  ident: B30
  article-title: Effect of aloe vera (Aloe barbadensis Miller) gel on doxorubicin-induced myocardial oxidative stress and calcium overload in albino rats
  publication-title: India J. Exp. Biol
– volume: 3
  start-page: 167
  year: 2012
  ident: B64
  article-title: Dysregulated lipid metabolism in cancer
  publication-title: World J. Biol. Chem.
  doi: 10.4331/wjbc.v3.i8.167
– volume: 275
  start-page: 8461
  year: 2000
  ident: B5
  article-title: Expression and functional analysis of Apaf-1 isoforms extra WD-40 repeat is required for cytochrome cbinding and regulated activation of procaspase-9
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.275.12.8461
– volume: 15
  start-page: 56
  year: 2016
  ident: B14
  article-title: Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
  publication-title: Lipids Health Dis.
  doi: 10.1186/s12944-016-0225-4
SSID ssj0000399364
Score 2.2519205
Snippet The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 314
SubjectTerms angiogenesis
apoptosis
cyclooxygenase
DuCLOX-2/5 inhibition
lipoxygenase
NMR
Pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF5KTrmUtulDfbGFEihEWDtaraSjm0fTUrehJOCb2Cc2pLKp5UOgP74zK8WxS2kvPeiyWqFF8-3MN-zoG8beVsI7CFCnkNdFKkHr1JQ-pMpAUBVSDBM7z02-qPMr-WlaTLdafVFNWC8P3H-4kaxLYzAwO6iCBOMrpSFkWioPCKXKkvfFmLeVTEUfTHFXyf5cErOwehSWM036n4JqJ3Mhd-JQlOv_E8f8vVRyK_acPWD3B9LIx_1iH7J7vn3EDi961embI3559xPV6ogf8os7PeqbA_bzZH38-es0hVHBP7azuYlVWnzcIV1eE9XE0YDA-B4P3Pm3vmrWc906Tp090JPwCW58dJStI7zy8XKx7Bar-Yoj5eUTHf9_4x-oSJKTAgF1VhnqKB-zq7PTy-PzdGi6kFqpoEsNhbQcWY72mYXC4FUEoZ0IogiutqWH3OUhs9Z5UZa2cgAiZFWdWUw9Mps_YXvtovXPGM8VJlfIKDSJ4AjhdGYrr0pEQS7BQkjY6NYEjR0UyakxxnWDmQkZrYlGa8hoUcNUJuzd5ollr8bxl7nvyaqbeaSjHQcQXc2AruZf6ErYm1tMNLjv6DBFt36xXuGLAH2XAKES9rTHyOZVeId4kEhYuYOenbXs3mnns6jtXVTIDwv1_H8s_gXbp88R64zUS7bX_Vj7V0ihOvM67pZflWYb5g
  priority: 102
  providerName: Directory of Open Access Journals
Title DuCLOX-2/5 Inhibition Attenuates Inflammatory Response and Induces Mitochondrial Apoptosis for Mammary Gland Chemoprevention
URI https://www.ncbi.nlm.nih.gov/pubmed/29681851
https://www.proquest.com/docview/2029631216
https://pubmed.ncbi.nlm.nih.gov/PMC5897656
https://doaj.org/article/497bb025d28f42be86a2f0a46e27948c
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQeOEFAeMjfExGQpOQFho7iZM8TKhsjIEoTGiV-hb5k1YaSWlSaZX447lzspaiiice8hLHsuU73_0uPv-OkFc5s4Y7XoQ8LtIw4VKGKrMuFIo7kQPEUL7y3OiLOB8nnybpZHM9ul_AZmdoh_WkxourN9c_V29hwx9jxAn-duDmU4nUngzTImOsan0b_FKG9QxGPdj3dhl9sUi6s8qdHbd8k6fw34U7_06f_MMfnd0jd3sgSYed5O-TW7Z6QA4vOibq1RG93Fysao7oIb3YcFSv9smv0-XJ56-TkA9S-rGazpTP3KLDFiD0EuEnvHWgLD_8ITz91mXSWiorQ7HaB1gXOgJjAOtXGdRhOpzX87ZuZg0FGExH0t-Jox8wcZIiKwFWW-lzKx-S8dn7y5PzsC_EEOpE8DZU6OZiQD7SRpqnCp7UMWmYY6kzhc4sj03sIq2NZVmmc8M5c1FeRBrCkUjHj8heVVf2CaGxgIALUIZEYhzGjIx0bkUGmhEnXHMXkMGNCErds5RjsYyrEqIVFFrphVai0DyvaRKQ1-se846h4x_fvkOprr9Dbm3_ol58L_utWiZFphRAQcNzl3BlcyG5i2QiLAfjleuAvLzRiRL2Ih6wyMrWywYG4mDPGGciII87HVkPBS2IjVhAsi3t2ZrLdks1m3q-7zQHzJiKp_9j8s_IHVwOn3sknpO9drG0LwBWterA_4448HvmN45kJRQ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DuCLOX-2%2F5+Inhibition+Attenuates+Inflammatory+Response+and+Induces+Mitochondrial+Apoptosis+for+Mammary+Gland+Chemoprevention&rft.jtitle=Frontiers+in+pharmacology&rft.au=Swetlana+Gautam&rft.au=Atul+K.+Rawat&rft.au=Shreesh+R.+Sammi&rft.au=Subhadeep+Roy&rft.date=2018-04-06&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=9&rft_id=info:doi/10.3389%2Ffphar.2018.00314&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon